Asymptomatic Severe Aortic Stenosis, When Should We Intervene?

Data from recent observational randomized studies suggest that most patients with asymptomatic severe aortic stenosis will eventually receive an indication for valve replacement.

Infarto agudo de miocardio y lesiones de múltiples niveles

 

Mortality in this “asymptomatic” population is caused not only by sudden death, but also by cardiac death. Early intervention may prevent these deaths as a consequence of aortic stenosis symptoms.

Researchers conducted a meta-analysis to learn about the natural contemporary history of asymptomatic severe aortic stenosis. Their main concern was all-cause death occurring during conservative treatment.

Cardiac death, death due to heart failure, sudden death, symptom onset, indication for aortic valve replacement, and aortic valve replacement were also assessed.

The primary endpoint of this study was comparing long-term mortality among patients receiving early intervention vs. those receiving conservative treatment (intervention only after symptom onset).


Read also: Intervention in Congenital Heart Disease.


A total of 4075 patients from 29 studies were analyzed.

Early intervention was associated with a significant reduction in long-term mortality (hazard ratio: 0.38; 95% confidence interval, 0.25-0.58).

Factors associated with worse prognosis in asymptomatic patients were severity of stenosis, low-flow, ventricular damage, and concomitant atherosclerotic disease.

Conclusion

Data from observational randomized studies suggest that the onset of symptoms in aortic stenosis may be cardiac death (such as heart failure), and not only sudden death. Other endpoints besides sudden death should be considered during the decision to perform early valve intervention.

jamacardiology_gahl_2020_oi_200043_1602688141-17564free

Original Title: Natural History of Asymptomatic Severe Aortic Stenosis and the Association of Early Intervention With Outcomes A Systematic Review and Meta-analysis.

Reference: Brigitta Gahl et al. JAMA Cardiol. 2020;5(10):1102-1112. doi:10.1001/jamacardio.2020.2497.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...